Injectable combination therapies for the management of diabetes: an Indian perspective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Injectable combination therapies for the management of diabetes: an Indian perspective

Published:2020-03-02 Issue:3 Volume:16 Page:209-216
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Dutta Deep¹,Khandelwal Deepak²,Kalra Sanjay³

Affiliation:

1. Department of Endocrinology, Center for Endocrinology Diabetes Arthritis & Rheumatism (CEDAR) Superspecialty Clinics, Dwarka, New Delhi, India

2. Department of Endocrinology, Maharaja Agrasen Hospital, New Delhi, India

3. Department of Endocrinology, Bharti Hospital, Karnal, India

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2020.1735351

Reference43 articles.

1. Intervening at prediabetes stage is critical to controlling the diabetes epidemic among Asian Indians

2. Neck circumference to height ratio is a reliable predictor of liver stiffness and nonalcoholic fatty liver disease in prediabetes

3. Comment on Anjana et al. Incidence of Diabetes and Prediabetes and Predictors of Progression Among Asian Indians: 10-Year Follow-up of the Chennai Urban Rural Epidemiology Study (CURES). Diabetes Care 2015;38:1441–1448

4. Factors Determining the Success of Therapeutic Lifestyle Interventions in Diabetes – Role of Partner and Family Support

5. A 2018 clinical practice pattern in the management of diabetes in India and Nepal: a three-city study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Ultra-rapid Lispro Insulin in Managing Type-1 and Type-2 Diabetes: A Systematic Review and Meta-Analysis;Indian Journal of Endocrinology and Metabolism;2023-11

2. Optimal use of once weekly icodec insulin in type-2 diabetes: An updated meta-analysis of phase-2 and phase-3 randomized controlled trials;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3